An open-label Phase I trial to evaluate the pharmacokine

Project: Research project

Project Details

Description

An open-label Phase I trial to evaluate the pharmacokinetics and safety profile of BAY 94-9027 following single and multiple dose administration in two cohorts of previously treated male subjects with severe hemophilia A
StatusFinished
Effective start/end date6/1/105/31/13

Funding

  • BAYER HEALTHCARE PHARMACEUTICALS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.